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Qian Zhan,1 Robert Korngold,2 Cecilia Lezcano,1 Frank McKeon,3 George F. Murphy1Acute graft-versus-host disease (GVHD), a major complication of allogeneic stem cell transplantation, in-
volves cytotoxic soluble and cellular effectors that selectively induce apoptosis in normally apoptosis-
resistant, cytokeratin 15 (K15)-expressing epithelial stem cells residing at the tips of rete ridges of human
epidermis and in analogous rete-like prominences (RLPs) of murine dorsal lingual epithelium. The mecha-
nisms whereby epithelial stem cells are rendered vulnerable to apoptosis during allostimulation are un-
known. We hypothesized that GVHD-induced target cell injury may be related to pathways involving the
p53 family that are constitutively expressed by epithelial stem cells and designed to trigger physiological ap-
optosis as a result of environmental danger signals. Among the p53 family members, we found that p73 pro-
tein and mRNA were preferentially expressed in K151 RLPs of murine lingual squamous epithelium. On
in vitro exposure to recombinant TNF-a and IL-1 in an organ culture model previously shown to replicate
early GVHD-like target cell injury, apoptosis was selectively induced in K151 stem cell regions and was as-
sociated with induction of phosphorylated p73, a marker for p73 activation, and apoptosis was abrogated in
target tissue obtained from p73-deficient (p732/2) mice. Evaluation of early in vivo lesions in experimental
murine GVHD disclosed identical patterns of phosphorylated p73 expression that coincided with the onset
of effector T cell infiltration and target cell apoptosis within K151 RLPs. This study is the first to suggest that
paradoxical apoptosis in GVHD of physiologically protected K151 epithelial stem cells is explainable, at least
in part, by cytokine-induced activation of suicide pathways designed to eliminate stem cells after exposure to
deleterious factors perceived to be harmful to the host.
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Acute graft-versus-host disease (GVHD) is an
enigmatic condition that ostensibly involves easily de-
ciphered interactions between relatively few donor ef-
fector cells and host target cells perceived by the
former as foreign. Extraordinary effort has been
expended over the past 3 decades to unravel the secrets
of how such deceptively basic immune responses pro-
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6/j.bbmt.2012.02.004mortality. One of the profound mysteries of GVHD
is how so few effector cells, as assessed in patient skin
and gut biopsy specimens, are responsible for such
clinically significant injury to critically protective and
functionally important epithelial elements that inter-
face with the external environment.
In 1996, we established that the predominant form
of epithelial cell injury in experimentalGVHDinvolved
apoptosis, and that the targeted subpopulations coin-
cidedwith regions previously designated to be enriched
in epithelial stem cells [1]. In 2003,Whitaker-Menezes
et al. [2], using dorsal lingual mucosa as a surrogate for
the human epidermal architecture, demonstrated that
the earliest injury in murine experimental GVHD in-
volved apoptosis of epithelial stem cells that normally
reside at the tips of rete ridge-like prominences
(RLPs), which, like human epidermal rete ridges that
are also preferentially targeted inGVHD[3], selectively
express the stem cell–associated biomarker cytokeratin
15 (K15) [4].Moreover, it was found that host epithelial
stem cell apoptosis identical to that seen in GVHD
could be replicated in vitro by exposing tissue explants
to TNF-a and IL-1, cytotoxic cytokines of established841
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tion. Subsequently, Zhan et al. [5] provided data indi-
cating that selective apoptosis of K151 basal cells
involved stem cell subpopulations that normally express
an apoptosis-resistant phenotype. Given that relatively
rare stem cells are critically important to epithelial ho-
meostasis, the selective targeting of epithelial stem cells
might provide insight into how relatively few donor ef-
fector cells can so efficiently produce injury to GVHD
target sites. Moreover, discovery of the mechanism(s)
responsible for the transition of antiapoptotic stem cells
to cells that express a proapoptotic profile has become
a fundamental issue for investigators concerned with
GVHD pathogenesis. In view of the fact that GVHD
and graft-versus-leukemia (GVL)/graft-versus-tumor
(GVT) interactions often occur in tandem and may
share common pathogenic pathways [6,7], the possible
involvement of cytotoxic immune mechanisms in
apoptotic targeting of cancer stem cells as a result of
allostimulation has not escaped our attention.
An intriguing possible explanation for apoptosis in
normally resistant epithelial stem cells lies in the fact
that these cells are equipped physiologically with sui-
cide genes designed to activate in certain settings, in-
cluding environmentally triggered mutational events
and exposure to various danger signals. This protective
attribute serves to purge damaged cells via induction of
apoptosis, a form of cell death that elicits minimal in-
flammatory injury but has potential dramatic structural
and functional consequences. Central to this response
is the p53 family, which includes molecules that are
highly conserved evolutionarily and serve as ‘‘guard-
ians of the genome’’ [8,9]. Both p63 and p73 bear
a structural and functional resemblance to p53, and
like p53 are involved in pleiotropic effects, including
cell cycle regulation and apoptosis induction. Lessons
from ablation studies show that in addition to its
role in apoptosis induction, p73 makes a unique
contribution to the survival and differentiation of
certain embryonic stem cell subpopulations [10].
Thus, p73 involves both stem cell maintenance as
well as apoptosis induction in cells threatened by dan-
ger signals or DNA damage, potentially linking its
expression and function to both cell types.
On DNA damage or perception of danger signals,
p73 is phosphorylated at tyrosine 99 by c-ABL, a non-
receptor tyrosine kinase that regulates its proapoptotic
function, resulting in translocation to the nuclearmatrix
[11]. c-ABL affects p73 by promoting direct phosphor-
ylation [12,13], as well as by enhancing its half-life [14]
and promoting its acetylation by p300 [15]. Along with
their role inpromoting cell death inducedbyDNAdam-
age, c-ABLandp73 are involved in apoptosis inducedby
TNF-a [16], a cytokine that, along with IL-1, is of key
importance in GVHD, where the so-called ‘‘cytokine
storm’’ drives early phases of the disease [17,18]. p73 is
also required for transmitting apoptotic signalsdownstream of TNF-a death receptor stimulation.
p73’s involvement of in transmitting both intrinsic and
extrinsic apoptotic signals underscores its importance
in apoptosis regulation [16]. With regard to host target
cell injury, exposure of murine lingual explants in vitro
to TNF-a alone, or to TNF-a and IL-1 in synergistic
combination, has been shown to result in apoptosis
that selectively involves K151 rete-associated stem cells
in a pattern remarkably similar to that of experimental
GVHD in vivo [2]. In terms of adult tissue stem cells,
itwas recently found that certainphysiological stemcells
(eg, neural and bone marrow mesenchymal stem cells)
selectively express functionally active p73 protein
[19,20]. Based on these and other associations, we
hypothesized that p73, and possibly other p53 family
members as well, may be involved in TNF-a–related
epithelial stem cell apoptosis in GVHD.
To test this hypothesis, we evaluated mRNA levels
in stem cell and non–stem cell compartments of mu-
rine lingual epithelium previously established to struc-
turally recapitulate epidermal rete ridges that are
targeted in human GVHD. Among the p53 family,
only p73 was localized exclusively to stem cell domains
based onmRNA expression and immunoreactivity. Al-
though exposure to TNF-a and IL-1 known to induce
preferential apoptosis in epithelial stem cells did not
alter the intensity or distribution of p73 immunoreac-
tivity or mRNA levels, these mediators resulted in ex-
pression of immunoreactive phosphorylated p73
selectively within the target epithelial stem cells, a find-
ing confirmed during the early phase of experimental
murine GVHD. Moreover, the ability of TNF-a and
IL-1 to induce apoptosis in the epithelial stem cell
niche was totally abrogated when target tissue was de-
rived from p73 knockout (p732/2) mice. These data
provide insight into the conundrum of how stem cells
selectively switch from an antiapoptotic state to a proa-
poptotic state in GVHD, and suggest that manipula-
tion of p73 may influence the threshold for injury to
critically important host stem cells during early phases
of disease initiation.MATERIALS AND METHODS
Animals
In vitro organ cultures were done using tongues
from 10- to 12-week-old female and male BALB/c
mice and p732/2 mice (courtesy of Frank McKeon),
as described previously [21]. For in vivo studies, an
H2d MHC-matched strain combination was used to
produce acuteGVHD across minor histocompatibility
antigen (miHA) barriers, as described previously [22].
Male B10.D2/oSnJ mice aged 7-12 weeks (Jackson
Laboratory, Bar Harbor, ME) were used as donors,
and male DBA/2Ncr mice aged 9-16 weeks (National
Cancer Institute Animal Production Program,
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B10.D2/DBA strain combination, acute GVHD
can result from allostimulation of CD41 donor T cells
by host miHA [22]. The mice were housed in a sterile
environment in microisolator cages (Lab Products,
Maywood, NJ) and provided with acidified water
(pH 2.5) and autoclaved food.
Antibodies
The primary antibodies used for immunohisto-
chemistry and immunofluorescence were rat anti-
mouse CD4 (BD Biosciences, San Diego, CA), mouse
anti-K15 (Thermo Fisher Scientific, Fremont, CA),
rabbit anti-p73 (Cell Signaling, Danvers, MA), rabbit
anti–phospho-p73 (Tyr99) (Abcam, Cambridge,
MA), and sheep anti–digoxigenin-peroxidase and
sheep anti–digoxigenin-fluorescein (Roche, Indianap-
olis, IN).
The secondary antibodies used were horse anti-
mouse IgG-peroxidase (Vector Laboratories, Burlin-
game, CA), goat anti-rabbit IgG-peroxidase (Vector
Laboratories), donkey anti-mouse IgG–Alexa Fluor
488 (Invitrogen, Carlsbad, CA), donkey anti-rabbit
IgG–Alexa Fluor 488 or 594 (Invitrogen), donkey
anti-rat IgG–Alexa Fluor 594 (Invitrogen).
Murine Tongue Organ Culture
Mouse dorsal tongues from 3 mice from each ex-
perimental group were prepared for organ culture as
described previously [2] by culturing in DMEM/F12
with 10% FBS, with or without added 250 U/mL of
IL-1 (PeproTech, Rocky Hill, NJ) and 2500 U/mL
of TNF-a (PeproTech) for 8 hours. The tongues
were collected after culture and embedded in optimal
cutting temperature medium.
Laser Capture Microdissection, RNA Isolation,
and cDNA Synthesis
Frozen sections of mouse tongue were fixed in
220C acetone for 5 minutes, then incubated with
1:50 mouse anti-K15 mAb and 1:200 peroxidase-
conjugated anti-mouse IgG in PBS with 0.8 U/ml of
RNaseOUT (Invitrogen, Carlsbad, CA) at 22C for
10 minutes. The sections were then washed briefly
with PBS solution, reacted with NovaRED substrate
(Vector Laboratories) for 1.5 minutes, and then
washed briefly with water. Sections were then dehy-
drated through the application of 95%-100% ethanol
(30 seconds each) and xylene (5 minutes), air-dried
for 5 minutes, and then immediately subjected to laser
capture microdissection, performed with a PixCell II
(Arcturus, Mountain View, CA). K151 rete ridge basal
cells and K152 basal cells were collected separately.
The collected cells were immediately placed into
RNA extraction buffer (Arcturus PicoPure RNA Isola-
tion Kit; Applied Biosystems, Foster City, CA), and thetotal RNA from each type of cells was isolated. Geno-
mic DNA from each RNA sample was removed from
each column with 40 ml of 0.34 U/ml DNase I (Qiagen,
Valencia, CA). The total RNA was finally eluted in
11 ml of elution buffer and was reverse-transcribed
into cDNAusing the SuperScript III First-Strand Syn-
thesis System for RT-PCR (Invitrogen).
PCR Array and Real-Time PCR
The apoptosis gene profiles of K151 and K152
basal cells were checked with RT2 Profiler PCR Array
for mouse apoptosis and the p53 pathway (Qiagen).
The expression of genes with significant difference be-
tween K151 and K152 basal cells were confirmed by
real-time PCR. All reagents for real-time PCR were
from Applied Biosystems. Real-time quantitative
PCR was performed on an Applied Bisosystems 7300
Real-Time PCR System in a 25-ml reaction mix con-
taining 1 ml of cDNA, 1 TaqMan Universal PCR
Master Mix, and 1  p53 or p73 or glyceraldehyde
3-phosphate dehydrogenase assay. Thermocycling
was carried out at 50C for 2 minutes and 95C for
10 minutes, followed by 40 cycles of 95C for 15 sec-
onds and 60C for 1 minute. All samples were run in
triplicate. The relative amounts of p53 and p73 tran-
scripts were analyzed using the 22DDCt method [23].
Immunohistochemistry and
Immunofluorescence
Tissue sections were fixed in acetone at220C for
5 minutes and then incubated with primary Ab, p73 or
phospho-p73 or K15 at 4 C overnight. After unbound
primary Ab was washed out, the sections were incu-
bated with peroxidase-conjugated secondary Ab at
22C for 30 minutes. Immunoreactivity was revealed
using NovaRed chromagen (Vector Laboratories).
For immunofluorescence double labeling, the sec-
tions were incubated with 2 primary Abs, K151
phospho-p73 or K151 p73 or CD41 phospho-p73,
at 4C overnight and then incubated with Alexa Fluor
488 or 594 conjugated secondary Ab at 22C for
1 hour. The sections were examined with a Nikon
Microphot SA fluorescence microscope (Nikon,
Melville, NY) attached to an Optronics digital camera
(Optronics, Goleta, CA).
Detection of Apototic Cells by Terminal
Deoxynucleotidyl Transferase Mediated dUTP
Nick End Labeling
For terminal deoxynucleotidyl transferasemediated
dUTP nick end labeling (TUNEL) analysis, frozen
sections were incubated with TdT solution (Chemi-
con/Millipore, Billerica, MA) or ddH2O solution (neg-
ative control) at 37C for 1 hour, and then incubated
with sheep anti-digoxigenin peroxidase at 22C for
30 minutes, developed with NovaRed substrate.
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Sections were incubated with TdT solution
(Chemicon/Millipore) or ddH2O solution as a negative
control at 37C for 1 hour. After incubation with
phospho-p73 Ab at 4C overnight, the sections were
further incubated with Alexa Fluor 594–conjugated
donkey anti-rabbit IgG and fluorescein-conjugated
sheep anti-digoxigenin Ab at 22C for 1 hour. Fluores-
cent labeling was examined with a Nikon Microphot
SA fluorescence microscope attached to an Optronics
digital camera.Transplantation Protocol
Anti–Thy-1.2 (J1j, ascites fluid, rat lgM)44 and
anti-CD8 (3.168, rat lgM)45 Ab were used for donor
transplant cell preparations. Anti–B cell Ab (goat
anti-mouse lgG) was purchased from ICN Immuno-
biologicals (Costa Mesa, CA). Guinea pig serum was
used as a source of complement. Donor cells were pre-
pared as described previously.43 Bone marrow cells
were obtained from the femur and tibia of donor
mice by flushing with buffered saline solution supple-
mented with 0.1% BSA (Hyclone, Logan, UT). To
prepare anti–Thy-1 treated (ie, T cell–depleted)
bone marrow (ATBM), cells were incubated with J1j
mAb antibody (diluted 1:100) and complement (di-
luted 1:25) for 45 minutes at 37C, followed by 4
washes. T cell–enriched donor cell populations were
prepared by treating pooled spleen and lymph node
cells with Gey’s balanced salt lysing solution, followed
by a low-ionic strength buffer to remove dead cells,
and then panning on plastic Petri dishes precoated
with goat anti-mouse lgG (40 mg/mL) for 1 hour at
4C to remove B cells. This treatment generally re-
sulted in a population of 90%-95% Thy-11 cells, as
measured for phenotyping by flow cytometry.
For preparation of purified T cell subset popula-
tions, T cell–enriched preparations were further
treated with the appropriate mAb directed against
the undesirable subset plus complement. To purify
CD41 T cells, lymphocytes were treated with anti-
CD8 mAb (3.168; diluted 1:50) plus complement
(1:25) for 45 minutes at 37C initially and then again
for 30 minutes, with a wash in between. Cells were
phenotyped by flow cytometry and were routinely
found to be negative for CD8.
Recipient mice were irradiated using a Gammacell
137Cs source (130 cGy/minute) (Atomic Energy of
Canada, Kanata, Canada). Approximately 6 hours
later, these recipients were injected with donor cells
i.v. via the tail vein. The inoculum consisted of either
ATBM cells (2  106) alone as a negative disease
control or a mixture of ATBM cells (2  106) and
donor-purified CD41 T cells (at 2-5  106 cells). Lin-
gual tissue from the day 4 and day 7 harvests (the timepoints associated with the earliest epithelial stem cell
alterations in our model) were evaluated for p73 phos-
phorylation status. Skin and tongue specimens from
days 4, 7, 14, and 21 (3 animals each for all experimen-
tal and control groups) were evaluated by routine his-
tology and CD4 immunohistochemistry to ensure that
GVHD developed subsequent to the earliest epithelial
alterations evidenced at day 7.
Statistical Analysis
The Wilcoxon rank-sum test and the Kruskal-
Wallis test were used to assess the differences in the
number of TUNEL-positive cells under various con-
trol and experimental conditions. Differences were
considered statistically significant at P\ .05.RESULTS
p73 Is Preferentially Expressed in the K15-
Positive Epithelial Niche
We initially interrogated K151 and K152 basal
layer niches in normal murine (BALB/c) dorsal lingual
mucosal tissue using immunoguided laser capture mi-
crodissection coupled with RT-PCRgene profiling for
mediators of apoptosis and p53 pathway members (84
genes per profiling chip; data not shown). We found
no difference in mRNA p53 and p63 expression by
K151 and K152 basal cells, but a dramatic difference
in favor of p73 expression by K151 cells.
To confirm this finding quantitatively, we per-
formed real-time RT-PCR analysis of p73 sequences
(Figure 1E) and found that p73 mRNA was nearly ex-
clusively restricted to the K151 niche. This was further
confirmed by detection of immunoreactive p73 pro-
tein predominantly within nuclei of K151 rete-
associated cells, but not in submucosal stromal cells,
by double labeling (Figure 1F-H). Moreover, restric-
tion of p73 protein to epithelial cells at the tips of epi-
dermal rete ridges of normal human skin was seen in
a pattern identical to that within the murine lingual
RLP (Figure 2C and F). Immunoreactive p53 and
p63 are not preferentially segregated between the
rete-associated and non–rete-associated basal cells, as
reported previously [24,25] (data not shown). Thus,
p73 is preferentially localized to epithelial niches
known to undergo apoptosis in experimental GVHD
and on exposure to cytotoxic cytokines [2].
p73 Is Retained During Induction of Cytokine-
Mediated Apoptosis
Because cytokine (TNF-a and IL-1)-mediated cy-
totoxicity is known to produce target cell apoptosis in
K151 epithelial cells identical to that seen in GVHD
[2], we next tested the hypothesis that p73 expression
might be affected in this model. Murine (BALB/c)
Figure 1. Association of p73 expression with K151 stem cell domains of murine dorsal lingual mucosa. (A) Immunohistochemistry for K15 discloses
discrete localization to stem cell regions at the tips and edges of the rete-like prominences (RLP). (B-D) RLP immunostained for K15 (B) are laser-
microdissected (C and D) and mRNA-extracted for RT-PCR analysis. Intervening K152 zones of the basal layer are similarly removed. (E) Although
p53 mRNA levels are expressed for both K151 (blue) and K152 (red) laser-dissected basal cells, p73 is detected only within the K151 microdomain.
(F-H) By dual-labeling, p731 nuclei are pink (mixture of blue nuclear staining and red p73 chromagen) (F) and are restricted to K151 cells (G andH; green)
at the tips of the RLP. DAPI-labeled nuclei are blue; omitted in H, and thus p73 appears red. The small red suprabasilar spots are extranuclear artifacts.
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IL-1 exhibited significant apoptosis, as assessed by
TUNEL reactivity and as described previously [2], af-
ter 8 hours and was localized to the tips of RLPs, al-
though the distribution and number of associated
p731 cells did not change (2-5 positive cells per RLP
tip; Figure 2A-D). Moreover, mRNA levels within
K151 microdissected niches were not significantly al-
tered before and after cytokine exposure (Figure 2E).
Thus, although p73 and K151 cells induced to un-
dergo the initiation of apoptosis by cytotoxic cytokinesare spatially coincident, induction of the apoptotic
pathway does not appear to influence qualitative or
quantitative measures of p73 expression.Immunoreactivity for Phosphorylated p73 Is
Associated with Cytokine-Mediated Apoptosis
of K151 Target Cells
One read-out of p73 activation is its phospho-
rylation status, and thus we next examined murine
(BALB/c) lingual organ cultures after exposure to
Figure 2. Effect of short-term exposure to TNF-a/IL-1 in vitro. (A and B) Compared with 8 hours in medium alone (A) murine lingual explants exposed
to TNF-a/Il-1 show prominent apoptosis in the vicinity of RLP tips by TUNEL staining (B, arrows). (C-E) Although these regions correspond to sites of
p73 intranuclear expression (C, 8-hour exposure to medium; (D) 8-hour exposure to TNF-a/IL-1), p73 immunoreactivity patterns did not change with
exposure to apoptosis-inducing cytokines, and by RT-PCR, mRNA levels also were not altered (E; a-c, K151 regions laser captured from 3 explants ex-
posed to medium [g, average]; d-f, K151 regions laser captured from 3 explants exposed to cytokines [h, average]). (F) Human epidermis demonstrated
a pattern of p73 distribution similar to the RLP, consistent with the established utility of the murine lingual model to study rete-associated stem cells.
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phophorylated p73 (p73phos). As opposed to medium
alone, explants exposed to cytotoxic cytokines for a de-
fined period known to induce early apoptosis showed
reproducible expression of p73phos exclusively within
the K151 niche (Figure 3), representing approximately
60%of the total p73positive cells.Moreover, double la-
beling for p73phos and TUNEL demonstrated precise
restriction of cells exhibiting evidence of early DNA
laddering with cells expressing p73phos. These associa-
tions further suggest a role for p73 activation in selec-
tive cytokine-mediated apoptosis of K151 target cells.
Sites of Target Cell Injury in Early Experimental
GVHD Involve Phosphorylated p73
To examine the potential physiological relevance
of these findings, we evaluated the well-established
B10.D2/DBA irradiation model of murine GVHD
induced by miHA differences where cutaneous target
cell injury is restricted to K151 RLP. In this model,
by day 7 posttransplantation, CD41 T cells first infil-
trate the RLP in association with the onset of apopto-
sis, as described previously [26]. As early as day 4, and
more prominently by day 7, these early targeting
events were associated with immunohistochemically
detectable intranuclear p73phos at or near the infil-
trated RLP tips in animals that received CD41 donor
T cells, but not in T cell–depleted controls (Figure 4).
Double labeling for CD4 and p73phos served to exclude
coexpression, thereby further implicating epithelial
cells within the targeted niche.Cytokine-Mediated Lingual Epithelial Apoptosis
Is Abrogated in p732/2 Mice
Finally, to provide proof of principle that cytokine-
mediated apoptosis of RLP lingual epithelial cells is
p73-dependent, we used mice genetically depleted of
p73 [21]. Whereas prominent TUNEL positivity of
RLP in WT lingual mucosa occurred after 8 hours
of exposure in vitro to TNF-a/IL-1, RLP from
p732/2 mice showed significantly less apoptosis (P 5
.016) and comparable positivity to WT and p732/2
mice exposed to medium alone (P 5 .42) (Figure 5).
Apoptosis within submucosal stromal cells was simi-
larly increased after TNF-a/IL-1 exposure in both
WT- and p732/2 -derived explants (P 5 .20), consis-
tent with nearly identical p73-independent cytokine-
induced biological effects in experimental settings.DISCUSSION
There is growing recognition that acute GVHD
involves early cytotoxicity that selectively involves
the apoptotic targeting of physiological epithelial
stem cells. For example, intestinal lesions of GVHD
are known to affect portions of crypt epithelium in
which stem cells normally reside. In the small intesti-
nal crypt, we have observed consistent depletion of
Paneth cells in murine experimental GVHD (data
not shown), a niche recently associated with Paneth
cell–driven Lgr5 stem cell maintenance [27]. Teshima
et al. [28] reported that mice treated with R-spondin1,
Figure 3. Dual staining for K15 and phosphorylated p73 (p73phos) and TUNEL and p73phos after exposure to TNF-a/IL-1 in vitro. Discrete regions of
reactivity for p73phos (single arrows) are detected within the K15
1 domains after cytokine but not medium exposure (K15, green; p73phos, red; upper 6
panels). Exposure to cytokines induces TUNEL-positive apoptosis (green; lower 4 panels) at the tips of RLP in intimate association with p73phos (red;
double arrows).
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sulted in amelioration of acute GVHD. Stems cells
in skin and squamous mucosa are localized to discrete
niches; in humans, they are concentrated at the tips of
epidermal rete ridges and in the bulge regions of hair
follicles [29,30], and in mice, the skin of which isdevoid of rete ridges, they are best documented in
the RLPs of the dorsal tongue as well in the
follicular bulge regions [30,31]. Of interest, all of
these sites express the stem cell–associated biomarker
K15, and all have been described as early cellular
targets in acute GVHD [2,3,32].
Figure 4. Correlation of p73 phos with early target cell injury in murine GVHD. DBAmicewere exposed to lethal irradiation and engrafted with B10.D2
ATBM cells alone or in addition to CD41T cells. Tissues were sampled from both groups at a time point correlating with earliest target cell injury (day 7).
In contrast to mice receiving the ATBM control inoculum (A) infiltration of the tips of RLP by CD41 effector T cells (B) is seen only in mice receiving the
CD4 effector inocula known to produce disease. At this juncture, and in contrast to controls (C) p73phos is observed within distorted and presumably
dying cells at or near the sites of effector cell homing (D). Double labeling (bottom) confirms that CD41 T cells are distinct from but focally in apposition
to those cells expressing p73phos.
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istic features, including slow cycling replication, a rela-
tively primitive phenotype, and apoptosis resistance. In
skin and squamous mucosa, stem cells known to ex-
press K15 and to be the earliest targets of GVHD-
induced injury are preferentially susceptible to the
proapoptotic effects of relevant cytotoxic cytokines
and correspond to sites for spatially restricted infiltra-
tion by specifically allostimulated Vb T cell subsets
[2,5,26]. Of interest, during the earliest phases
accompanying the onset of apoptosis and effector
T cell infiltration of the K151 stem cell niche,
epithelial targets preferentially express cytokine-
inducible adhesion molecules, such as CD106, signify-
ing the coincident and selective effect of solubleinflammatory mediators [26]. From these findings has
evolved the hypothesis that coordinated influences of
cytotoxic soluble and cellular mediators may conspire
to induce apoptosis in target stem cell subpopulations
that normally express an antiapoptotic repertoire [5].
However, the role of p73 in cell-mediated pathways
to apoptosis requires further study. Nonetheless, ec-
topic overexpression of p73, as well as its activation
by cisplatin in an astrocytoma cell line, are known to
up-regulate the transcription of Fas, and that this path-
way induces programmed cell death through the cas-
pase cascade [33]. Data on p73-induced apoptosis and
its possible involvement in cancer stem cell targeting
are also scarce. Recently, p73 along with p63 and p53
were linked to the regulation of a number of
Figure 5. Effect of TNF-a/IL-1 on murine lingual target cell apoptosis in lingual organ cultures from wild-type (WT) and p732/2 mice. Whereas WT
mice showed TUNEL-positive cells within both the epithelial and subepithelial layers, p732/2 mice had TUNEL-positive cells only in the subepithelial
region (upper panels, lower magnification; middle panels, higher magnification). The numbers of TUNEL-positive subepithelial cells were not statistically
different between TNF-a/IL-1–exposed in WTand p732/2 explants (graph, upper right; P 5 .20). However, the numbers of epithelial TUNEL-positive
cells in the RLP regions of WTexplants significantly exceeded those in TNF-a/IL-1–exposed p732/2 animals (P5 .016), which did not significantly differ
from the rare TUNEL-positive epithelial apoptotic cells seen in WTand p732/2 explants exposed to medium alone (graph, lower right; P 5 .42).
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hibiting tumorigenesis, invasion, metastasis, and can-
cer stem cell proliferation in malignancies of diverse
lineage, including acutemyelogenous and lymphoblas-
tic leukemia, glioblastoma, adenocarcinoma of the
lung, ovarian carcinoma, and B cell lymphoma [34-
36]. Because human tumors have a low frequency of
mutatedp73 [37], regulation of p73maypresent a novel
therapeutic opportunity in a broad number of malig-
nancies to develop targeting approaches that could be
successful in reducing tumor aggressiveness.
The induction of apoptosis in a normally protected
stem cell niche raised the possibility of involvement
of factors designed to eliminate these critical cells on
genetic damage or oncogenic signaling—namely,
members of the p53 family. Themechanisms and path-
ways through which p53, p63, and p73 induce apopto-
sis are complex, however. In a previous study of
experimental murine GVHD, we observed prominent
expression ofBax, a propapoptoticmember of theBcl-2
protein family, within the K151 niche at very early
time points, associated with the initiation of apoptotic
injury [5]. One link between stem cells and Bax expres-
sion is the p53 family member p73, which is known to
mediate induction of PUMA (p53 up-regulated modu-lator of apoptosis), which in turn causes Bax mito-
chrondrial translocation and cytochrome c release
[38]. p73 is of special interest among the p53 family
members in stem cell biology, because it has an estab-
lished functional association with physiological stem
cells of certain lineages [39]. The findings reported
herein provide a potential link among p73, Bax, and
K151 stemcell apoptosis and suggest that the p73path-
way may be important to understanding the underpin-
nings of target cell injury in early acute GVHD.
The apoptotic injury to the K151 target cell niche
may be replicated by exposure of short-term murine
lingual organ cultures to cytokines (TNF-a and IL-
1) relevant to the early soluble phases of GVHD (the
so-called ‘‘cytokine storm’’ [17,18]). TNF-a–induced
apoptosis is mediated by both mitochondrion-
dependent andmitochondrion-independent pathways.
Nuclear c-ABL tyrosine kinase, an inducer of apopto-
sis and a regulator of both p53 and p73 function, is
activated by TNF-a [40]. Although activated nuclear
c-ABL can induce apoptosis in p53-deficient cells, it
does not induce apoptosis in cells deficient in p73,
which it serves to directly phosphorylate [11,16].
Thus, coexpression of activated nuclear c-ABL
kinase and p73 synergistically activates cell death and
850 Biol Blood Marrow Transplant 18:841-851, 2012Q. Zhan et al.thus may cooperate to promote TNF-a–driven
apoptosis [16]. Our findings support a role for cooper-
ative influences of TNF-a and p73 in the induction of
apoptosis of K151 target cells, and provide a novel ex-
planation of how soluble phases of GVHD may
‘‘prime’’ normally resilient stem cells by triggering
a proapoptotic phenotype via the very pathways (p73)
normally intended to activate only on irrevocable in-
jury perceived as potentially injurious to the host.
Such cytokine-primed cells would then be even more
vulnerable to the effects of allostimulated T cells pre-
viously established to home directly to the stem cell
niche [2].
The potential translational significance of p73-
associatedapoptosis inK151 epithelial stemcells as a re-
sult of cytotoxic cytokines and experimental GVHD
merits mention. Our results in p732/2 mice strongly
suggest that ablation of this stem cell–associated apo-
ptosis pathway may ameliorate early, cytokine-driven
target cell injury in GVHD [40]. It is important to con-
sider that even if all target cell apoptosis cannot be fully
eliminated in vivo, p73-mediated pathologymight be of
key importance, because it may involve the stem cell
component of skin and gut required to replenish and
maintain the organ in homeostatic equilibrium.
Pifithrin-alpha is a pharmacologic inhibitor of p53
that has been shown to inhibit p73 function in amanner
analogous to that of antisensemorpholino oligonucleo-
tides used to reduce p73 expression [41], and this and
similar approaches to blunting p73-associated apopto-
sis in GVHD may hold promise as well.
GVHDis a complex disorder that involves initial al-
lostimulation, induction of both soluble and cellular cy-
totoxic pathways, homing of effector mediators to
target tissues, and ultimately target cell injury. These
phases of disease progression each exhibit molecular
features potentially susceptible to therapeutic interven-
tion. In previous work, we proposed that a novel
method for amelioration of GVHDmay involve devel-
opment of strategies to protect the host cells targeted
for apoptosis [42].Oneobvious approachwould involve
modifying stem cells to thwart allostimulation-
mediated engagement of apoptotic pathways intended
for self-elimination of stem cells on environmental
damage or exposure danger signals. Now that stem
cell–directed apoptosis relevant toGVHD is associated
with selective expression and activation of p73, new ap-
proaches for target cell protection as ameans of treating
this potentially lethal complication of hematopoietic
stem cell transplantation merit further inquiry.ACKNOWLEDGMENTS
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